The global Cell and Gene Therapy Market was valued at US$ 13.90 Billion in 2024 and is projected to reach US$ 105.83 Billion by 2033, growing at a CAGR of 21.5% during 2025–2033. Growth is being driven by rising prevalence of genetic disorders, cancers, and rare diseases, coupled with advancements in biotechnology, regenerative medicine, and personalized therapeutics. Cell and gene...